Author: admin

Incoming health policy doctoral student Lyndon James, and current global and population health doctoral student Allison Portnoy, were honored with awards from the

Antibiotic resistance can develop through antibiotic use – but what other factors can influence the spread of antibiotic resistance? Researchers from Harvard Medical School, Boston Children’s Hospital,

Carlos Castañeda-Orjuela presented a project on the use of cost-effectiveness analysis (CEA) for pneumococcal vaccines (PV) in Latin American countries at a CHDS research seminar.

CHDS’ Nicolas Menzies and colleagues estimate that the U.S. is unlikely to eliminate tuberculosis (TB) before the end of the 21st century. Menzies and collaborators

The Immunization Economics global collaborative has recently launched the Immunization Delivery Cost Catalogue: the most comprehensive, current, and standardized

CHDS faculty Ankur Pandya makes the case for using cost-effectiveness analysis to define low-value care in “Adding Cost-Effectiveness to Define Low-Value Care” published in JAMA.

Doctoral candidate Zach Ward volunteers with Harvard’s Project Teach to teach middle school students about infectious disease modeling. Project Teach helps students develop

CHDS welcomes Lyndon James and Karen Smith to the PhD Program in Health Policy decision science track beginning Fall 2018. Lyndon James is currently a Research Assistant at CHDS

A recent self-driving Uber vehicle collision that left a pedestrian dead provoked a national dialogue on urbanization, road safety, and technology. This accident highlights the challenges

Regulations have a substantial impact on public health in the United States and elsewhere, affecting our exposure to environmental, transportation, food, tobacco, terrorism, and other risks.